Literature DB >> 8982614

Do we believe what patients say about their neoplastic symptoms? An analysis of factors that influence the interviewer's judgement.

M Porta1, N Malats, J Belloc, M Gallén, E Fernandez.   

Abstract

In order to analyze factors that influence an interviewer's judgement of the validity of responses given by patients on the duration of their neoplastic signs and symptoms, 183 consecutive symptomatic patients hospitalized for a digestive tract neoplasm were personally interviewed. The validity of the answers was judged by the interviewers to be high in 156 cases (85%), and low in 27 (15%). The subjective validity of the interview (SVI) was inversely related to the time elapsed from first medical symptom to interview (TFMSI), even after adjusting for the duration of the interview (p < 0.05). SVI was not influenced by whether patient and interviewer agreed on the first symptom. SVI was inversely related to educational level (p < 0.01) and to occupational class (p = 0.04). Patients whose Karnofsky's Index (KI) was > or = 80 were over twice as likely to yield valid responses (TFMSI-adjusted odds ratio [OR] = 2.82, p = 0.037). Multivariate analyses selected education, TFMSI and KI as independent predictors of the interviewer assessment. The SVI of patients admitted to the hospital through the Emergency Department was lower than that of subjects whose admission was planned (OR = 6.49, p = 0.005). In this study SVI related in a logical manner to the characteristics of the interview, of the subjects and of their clinical course. It hence appeared to reasonably estimate the validity of data collected. Identifying factors that affect the reliability of patients' responses would help increase the validity of studies on the duration of cancer symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 8982614     DOI: 10.1007/bf00499453

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  65 in total

1.  Determinants of acceptance to education and utilization of services for cancer detection and care among low-income groups.

Authors:  H H WHITTED
Journal:  Med Ann Dist Columbia       Date:  1962-01

2.  Carcinoma of the esophagus; a review of 381 cases admitted to Toronto General Hospital, 1937-1953 inclusive.

Authors:  O IBBERSON; R A MUSTARD
Journal:  Ann Surg       Date:  1956-12       Impact factor: 12.969

3.  Analysis of survival versus patient and doctor delay of treatment in gastrointestinal cancer.

Authors:  B S Lim; C R Dennis; B Gardner; J Newman
Journal:  Am J Surg       Date:  1974-02       Impact factor: 2.565

4.  Carcinoma of the oesophagus: factors influencing survival.

Authors:  J D Younghusband; A P Aluwihare
Journal:  Br J Surg       Date:  1970-06       Impact factor: 6.939

5.  Impact of delay in diagnosis on clinical stage of testicular cancer.

Authors:  G J Bosl; N J Vogelzang; A Goldman; E E Fraley; P H Lange; S H Levitt; B J Kennedy
Journal:  Lancet       Date:  1981-10-31       Impact factor: 79.321

6.  Delay in diagnosis of cancer. Possible effects on the stage of disease and survival.

Authors:  E Robinson; J Mohilever; J Zidan; D Sapir
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

7.  Delay in diagnosis of gastric cancer: a prospective study evaluating doctors'- and patients' delay and its influence on five year survival.

Authors:  T L Zilling; B S Walther; B Ahren
Journal:  Anticancer Res       Date:  1990 Mar-Apr       Impact factor: 2.480

8.  Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites.

Authors:  M Porta; M Gallén; N Malats; J Planas
Journal:  J Epidemiol Community Health       Date:  1991-09       Impact factor: 3.710

9.  Delayed access to health care: risk factors, reasons, and consequences.

Authors:  J S Weissman; R Stern; S L Fielding; A M Epstein
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

10.  Disagreement between hospital medical records and a structured patient interview on the type and date of the first symptom in cancers of the digestive tract.

Authors:  N Malats; J Belloc; M Gallén; M Porta
Journal:  Rev Epidemiol Sante Publique       Date:  1995-12       Impact factor: 1.019

View more
  9 in total

1.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

2.  Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study.

Authors:  Miquel Porta; José Pumarega; Olga Ferrer-Armengou; Tomàs López; Joan Alguacil; Núria Malats; Esteve Fernàndez
Journal:  Eur J Epidemiol       Date:  2007-07-18       Impact factor: 8.082

3.  Symptom-to-diagnosis interval and survival in cancers of the digestive tract.

Authors:  Esteve Fernandez; Miquel Porta; Núria Malats; Josep Belloc; Manuel Gallén
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

4.  [Family practice and diagnosis of cancer].

Authors:  A Ruiz-Torrejón; M Ramos-Monserrat; J Llobera-Cánaves
Journal:  Aten Primaria       Date:  2006-01       Impact factor: 1.137

5.  Development and validation of a questionnaire to assess delay in treatment for breast cancer.

Authors:  Karla Unger-Saldaña; Ingris Peláez-Ballestas; Claudia Infante-Castañeda
Journal:  BMC Cancer       Date:  2012-12-28       Impact factor: 4.430

6.  Emergency admission for cancer: a matter of survival?

Authors:  M Porta; E Fernandez; J Belloc; N Malats; M Gallén; J Alonso
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

7.  Patient delay and stage of diagnosis among breast cancer patients in Germany -- a population based study.

Authors:  V Arndt; T Stürmer; C Stegmaier; H Ziegler; G Dhom; H Brenner
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

8.  The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia.

Authors:  Philippa H Youl; Joanne F Aitken; Gavin Turrell; Suzanne K Chambers; Jeffrey Dunn; Christopher Pyke; Peter D Baade
Journal:  Int J Environ Res Public Health       Date:  2016-11-19       Impact factor: 3.390

9.  Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study.

Authors:  Mostafa Dianatinasab; Mohammad Fararouei; Mohammad Mohammadianpanah; Mohammad Zare-Bandamiri
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.